Summary

The medical filtration market is projected to reach USD 9.35 billion by 2030 from USD 6.29 billion in 2024, at a CAGR of 6.8%. The urgent demand for quality filtration solutions serves as a major driving force for this market, especially with healthcare providers and research institutions prioritizing patient safety along with effective products. Advanced filtration technologies that ensure the removal of contaminants have therefore become paramount. This trend is majorly influenced by stringent regulatory standards and rising importance of maintaining sterile environments in medical settings. There is also growing demand for reliable filtration systems to support clinical and diagnostics applications, supported by the increase in chronic diseases in laboratories. Hence, the companies have ample opportunities to innovate and develop specialized filtration products catering to such evolving needs and enhancing their market presence and driving future growth.
“Based on material, PVDF is the second fastest growing material in medical filtration market during the forecast period, in terms of value.”
PVDF is the second-fastest-growing material in the medical filtration market due to its exceptional chemical resistance, high thermal stability, and excellent mechanical properties. These properties make it very suitable for demanding medical applications like sterile filtration and membrane-based devices. Compatibility with a wide range of sterilization techniques such as autoclaving and gamma radiation makes PVDF highly useful in medical filtration. Its hydrophobic nature and resistance to aggressive cleaning agents also make it increasingly popular. As healthcare and bioprocessing technologies advance, the demand for strong and efficient filtration materials grow increasing the adoption of PVDF .
“Based on end-use industry, hospitals account the largest share in medical filtration market during the forecast period, in terms of value.”
The largest market share of the medical filtration market is captured by hospitals due to their role in infection prevention and patient safety. In fact, rising hospital admissions on account of surging chronic diseases, surgical procedures, and the aging population is boosting the demand for advanced filtration systems. Hospitals rely heavily on filtration solutions in terms of sterile air and water for medical devices including ventilators, IV infusion systems, and surgical tools. Growth in infection control in hospitals coupled with the necessity to meet severe regulatory standards leads to further growth in adoption. Moreover, developing healthcare infrastructure in many emerging economies contributes to hospitals' being the top end-use industry.
“Based on region, North America accounts the largest share and Asia pacific is the fastest growing region in medical filtration market, in terms of value.”
North America accounts the largest share in medical filtration market majorly because of its developed healthcare infrastructure, strict regulatory standards, and high expenditure on healthcare services. This is further fueled by significant presence of major medical filtration manufacturing companies in the region with high demands for advanced filtration solutions. Increased prevalence of chronic diseases along with an aging population has created a need for more filtration systems within hospitals, laboratories, and in home care. Infection control, as also seen within the North America, has further added to the use of advanced filtration technologies following COVID-19. Asia Pacific is a rapidly growing market for medical filtration, supported by rapid urbanization, expansive healthcare infrastructure growth, and the increasing investments being made in medical industries. Its large and aging population, with improved awareness of healthcare hygiene, encourages the consumption of medical filtration products. China and India are significant emerging economies since the governments and medical tourism drive the country to grow more rapidly.
In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:
• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: Directors- 35%, Managers - 25%, and Others - 40%
• By Region: North America - 22%, Europe - 22%, Asia Pacific - 45%, RoW – 11%
The key players in this market are Merck KGaA (Germany), 3M (Solventum) (US), Danaher (US), Sartorius AG (Germany), Veolia (France), Thermo Fisher Scientific Inc (US), Donaldson Company Inc (US), Baxter (US), Parker Hannifin Corp (US), Entegris (US), Asahi Kasei Corporation (Japan), and Mann+Hummel (Germany).
Research Coverage
This report segments the medical filtration market based on material, process technology, design/process, application, end-use industry, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions associated with the medical filtration market.
Key benefits of buying this report
This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the medical filtration market, high-growth regions, and market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (Growing demand for high quality filtration solutions, Regulatory and quality standards and Growing focus on infection control), restraints (High cost of advanced filtration systems), opportunities (Growing healthcare investment in emerging economies and Advancements in filtration technologies) and challenges (Disposal of filters and Product performance variability).
• Market Penetration: Comprehensive information on the medical filtration market offered by top players in the global medical filtration market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the medical filtration market.
• Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for medical filtration market across regions.
• Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global medical filtration market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the medical filtration market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.3 STUDY SCOPE 33
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 33
1.3.2 INCLUSIONS & EXCLUSIONS 34
1.3.3 YEARS CONSIDERED 34
1.3.4 CURRENCY CONSIDERED 34
1.3.5 UNITS CONSIDERED 34
1.4 STAKEHOLDERS 35
1.5 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
2.1.1 SECONDARY DATA 37
2.1.1.1 List of key secondary sources 37
2.1.1.2 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Key data from primary sources 38
2.1.2.2 List of key primary interview participants 39
2.1.2.3 Key industry insights 39
2.1.2.4 Breakdown of interviews with experts 39
2.2 MARKET SIZE ESTIMATION 40
2.2.1 BOTTOM-UP APPROACH 40
2.2.2 TOP-DOWN APPROACH 41
2.3 GROWTH FORECAST 42
2.4 DATA TRIANGULATION 43
2.5 FACTOR ANALYSIS 44
2.6 RESEARCH ASSUMPTIONS 44
2.7 RESEARCH LIMITATIONS AND RISK ANALYSIS 45
3 EXECUTIVE SUMMARY 46
4 PREMIUM INSIGHTS 50
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL FILTRATION MARKET 50
4.2 MEDICAL FILTRATION MARKET, BY MATERIAL 50
4.3 MEDICAL FILTRATION MARKET, BY APPLICATION 51
4.4 MEDICAL FILTRATION MARKET, BY END USER 51
4.5 MEDICAL FILTRATION MARKET, BY KEY COUNTRY 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
5.2.1 DRIVERS 54
5.2.1.1 Increasing demand for advanced healthcare solutions 54
5.2.1.2 Rising awareness of infection control 56
5.2.1.3 Technological advancements 56
5.2.2 RESTRAINTS 56
5.2.2.1 High capital investments 56
5.2.2.2 Stringent regulatory compliance 57
5.2.3 OPPORTUNITIES 57
5.2.3.1 Growing healthcare investments in emerging economies 57
5.2.3.2 Adoption of single-use technologies 57
5.2.4 CHALLENGES 58
5.2.4.1 Speed and yield issues 58
5.3 PORTER’S FIVE FORCES ANALYSIS 59
5.3.1 THREAT OF NEW ENTRANTS 59
5.3.2 THREAT OF SUBSTITUTES 60
5.3.3 BARGAINING POWER OF SUPPLIERS 60
5.3.4 BARGAINING POWER OF BUYERS 60
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 60
5.4 KEY STAKEHOLDERS AND BUYING CRITERIA 61
5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS 61
5.4.2 QUALITY 62
5.4.3 SERVICE 62
5.5 MACROECONOMIC OUTLOOK 63
5.5.1 GDP TRENDS AND FORECASTS 63
5.6 IMPACT OF AI/GEN AI 66
5.7 VALUE CHAIN ANALYSIS 67
5.7.1 RAW MATERIAL SUPPLIERS 67
5.7.2 MANUFACTURERS 67
5.7.3 DISTRIBUTORS 67
5.7.4 END USERS 68
5.8 ECOSYSTEM ANALYSIS 68
5.9 CASE STUDY ANALYSIS 69
5.9.1 VALIDATING PEGASUS PRIME VIRUS REMOVAL FILTERS WITH PREFILTERS 69
5.9.2 ENHANCING DIALYSIS FILTRATION EFFICIENCY – FRESENIUS MEDICAL CARE 70
5.9.3 BLOOD FILTRATION FOR SEPSIS TREATMENT – CYTOSORBENTS CORPORATION 71
5.10 TARIFF AND REGULATORY LANDSCAPE 71
5.10.1 ENVIRONMENTAL REGULATIONS 71
5.10.2 NORTH AMERICA 71
5.10.3 ASIA PACIFIC 72
5.10.4 EUROPE 72
5.10.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
5.11 TECHNOLOGY ANALYSIS 75
5.11.1 KEY TECHNOLOGIES 75
5.11.1.1 Microfiltration 75
5.11.1.2 Ultrafiltration 75
5.11.1.3 Nanofiltration 75
5.11.2 COMPLEMENTARY TECHNOLOGIES 76
5.11.2.1 Single-use technology 76
5.11.3 ADJACENT TECHNOLOGIES 76
5.11.3.1 Chromatography 76
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 77
5.13 TRADE ANALYSIS 78
5.13.1 EXPORT SCENARIO (HS CODE 8421) 78
5.13.2 IMPORT SCENARIO (HS CODE 8421) 79
5.14 KEY CONFERENCES AND EVENTS, 2025–2026 80
5.15 PRICING ANALYSIS 82
5.15.1 AVERAGE SELLING PRICE TREND, BY REGION, 2021–2023 82
5.15.2 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021–2023 83
5.15.3 AVERAGE SELLING PRICE TREND, BY END USER, 2021–2023 83
5.16 INVESTMENT AND FUNDING SCENARIO 84
5.17 PATENT ANALYSIS 84
5.17.1 INTRODUCTION 84
5.17.2 LEGAL STATUS OF PATENTS 86
5.17.3 JURISDICTION ANALYSIS 86
6 MEDICAL FILTRATION MARKET, BY MATERIAL 87
6.1 INTRODUCTION 88
6.2 POLYSULFONE & POLYETHERSULFONE 90
6.2.1 EXCELLENT MECHANICAL STRENGTH, THERMAL STABILITY, AND CHEMICAL RESISTANCE TO BOOST MARKET 90
6.3 POLYVINYLIDENE FLUORIDE 90
6.3.1 EXCEPTIONAL CHEMICAL RESISTANCE, THERMAL STABILITY, AND MECHANICAL STRENGTH TO DRIVE MARKET 90
6.4 POLYTETRAFLUOROETHYLENE 91
6.4.1 SUPERIOR FILTRATION PERFORMANCE IN CRITICAL MEDICAL APPLICATIONS TO PROPEL DEMAND 91
6.5 POLYPROPYLENE 91
6.5.1 EXCELLENT CHEMICAL RESISTANCE, DURABILITY, AND COST-EFFECTIVENESS TO DRIVE DEMAND 91
6.6 OTHER MATERIALS 92
7 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY 93
7.1 INTRODUCTION 94
7.2 ULTRAFILTRATION 96
7.2.1 INCREASING PREVALENCE OF CHRONIC KIDNEY DISEASE AND RISING DEMAND FOR DIALYSIS TREATMENTS TO BOOST MARKET 96
7.3 MICROFILTRATION 96
7.3.1 GROWING USAGE IN STERILIZATION, WATER PURIFICATION, AND BIOPHARMACEUTICAL MANUFACTURING TO DRIVE DEMAND 96
7.4 NANOFILTRATION 97
7.4.1 LOW ENERGY CONSUMPTION AND HIGH FILTRATION EFFICIENCY TO SUPPORT MARKET GROWTH 97
7.5 REVERSE OSMOSIS 97
7.5.1 CRUCIAL ROLE IN ENSURING SAFETY OF WATER IN MEDICAL PROCEDURES TO BOOST MARKET 97
7.6 GAS FILTRATION 98
7.6.1 DELIVERY OF HIGH-QUALITY FILTERED AIR TO FUEL GROWTH 98
7.7 OTHER PROCESS TECHNOLOGIES 98
8 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS 99
8.1 INTRODUCTION 100
8.2 SYSTEMS (RTU UNITS) 101
8.2.1 CONVENIENCE, TIME-SAVING BENEFITS, AND ABILITY TO ENSURE CONSISTENT FILTRATION PERFORMANCE TO BOOST MARKET 101
8.3 FILTRATION MODULES (CONSUMABLES) 102
8.3.1 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND FOR FILTRATION MODULES IN HEALTHCARE 102
8.4 OTHER DESIGNS/PROCESSES 102
9 MEDICAL FILTRATION MARKET, BY END USER 103
9.1 INTRODUCTION 104
9.2 HOSPITALS 106
9.2.1 REQUIREMENT OF HIGH-PURITY WATER FOR WOUND CARE, SURGICAL PROCEDURES, STERILIZATION, AND DIALYSIS TO DRIVE MARKET 106
9.3 DIAGNOSTIC CENTERS 106
9.3.1 DEMAND FOR HIGH-PURITY WATER, FLUIDS, AND AIR TO ENSURE RELIABLE DIAGNOSTICS TO DRIVE GROWTH 106
9.4 RESEARCH INSTITUTES 107
9.4.1 INCREASE IN BIOLOGICAL STUDIES, AND MEDICAL RESEARCH TO BOOST MARKET 107
9.5 OTHER END USERS 107
 
10 MEDICAL FILTRATION MARKET, BY APPLICATION 108
10.1 INTRODUCTION 109
10.2 DIALYSIS 111
10.2.1 ACCURACY AND OPERATIONAL FILTRATION EFFICIENCY IN BLOOD PURIFICATION TO BOOST GROWTH 111
10.3 DRUG DELIVERY 111
10.3.1 PROVISION OF OPTIMAL CONDITIONS THROUGH CONSISTENT FLOW RATES AND MINIMUM PRESSURE DROPS TO FUEL MARKET GROWTH 111
10.4 IV INFUSION & STERILE FILTRATION 112
10.4.1 HIGH LEVEL OF PRECISION IN CONTAMINANT REMOVAL WHILE PRESERVING FLUID INTEGRITY TO DRIVE GROWTH 112
10.5 ENDOSCOPY 112
10.5.1 ENHANCEMENT OF SAFETY AND PERFORMANCE WITH ADVANCED FILTRATION TO BOOST MARKET 112
10.6 STERILE PROCESSING 113
10.6.1 GROWING DEMAND FOR SURGICAL INSTRUMENTS, ENDOSCOPES, AND REUSABLE MEDICAL DEVICES TO PROPEL MARKET 113
10.7 BIO-ARTIFICIAL PROCESSES 113
10.7.1 VITAL ROLE OF SOPHISTICATED FILTRATION SYSTEMS IN DEVELOPMENT AND FUNCTIONALITY OF BIO-ARTIFICIAL ORGANS TO BOOST MARKET 113
10.8 OTHER APPLICATIONS 114
11 MEDICAL FILTRATION MARKET, BY REGION 115
11.1 INTRODUCTION 116
11.2 ASIA PACIFIC 118
11.2.1 CHINA 127
11.2.1.1 Strong economic growth and expanding healthcare sector to drive market 127
11.2.2 JAPAN 129
11.2.2.1 Growing aging population to propel market 129
11.2.3 INDIA 131
11.2.3.1 Increasing investments in healthcare sector to drive market 131
11.2.4 SOUTH KOREA 133
11.2.4.1 Rising demand for high-quality medical filtration solutions to drive market 133
11.2.5 REST OF ASIA PACIFIC 135
11.3 EUROPE 137
11.3.1 GERMANY 146
11.3.1.1 Economic strength, increasing healthcare expenditure, and rapidly aging population to drive market 146
11.3.2 UK 148
11.3.2.1 Rising geriatric population to support market growth 148
11.3.3 FRANCE 150
11.3.3.1 Aging population and enhancement of healthcare system to propel market 150
11.3.4 ITALY 151
11.3.4.1 Growing aging population to increase demand 151
11.3.5 SPAIN 153
11.3.5.1 Rising demand for advanced medical solutions to propel market 153
11.3.6 REST OF EUROPE 155
11.4 NORTH AMERICA 157
11.4.1 US 165
11.4.1.1 Stringent regulatory guidelines and increasing healthcare spending to boost market 165
11.4.2 CANADA 167
11.4.2.1 Growing aging population and significant government investments in healthcare infrastructure to drive market growth 167
11.4.3 MEXICO 169
11.4.3.1 Government initiatives and growth of healthcare sector to drive market 169
11.5 MIDDLE EAST & AFRICA 171
11.5.1 GCC COUNTRIES 179
11.5.1.1 Saudi Arabia 179
11.5.1.1.1 Economic growth, increasing government investments, and rising healthcare expenditures to drive market 179
11.5.1.2 Rest of GCC Countries 181
11.5.2 SOUTH AFRICA 183
11.5.2.1 Outbreaks of contagious diseases to drive demand 183
11.5.3 REST OF MIDDLE EAST & AFRICA 184
11.6 SOUTH AMERICA 186
11.6.1 BRAZIL 194
11.6.1.1 Rising healthcare investments and expanding medical infrastructure to propel growth 194
11.6.2 ARGENTINA 195
11.6.2.1 Increasing healthcare expenditure and enhancement of medical infrastructure to drive market 195
11.6.3 REST OF SOUTH AMERICA 197
12 COMPETITIVE LANDSCAPE 200
12.1 OVERVIEW 200
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 200
12.3 REVENUE ANALYSIS, 2021–2023 202
12.4 MARKET SHARE ANALYSIS, 2023 203
12.5 COMPANY VALUATION AND FINANCIAL METRICS 205
12.6 PRODUCT COMPARISON 206
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 207
12.7.1 STARS 207
12.7.2 EMERGING LEADERS 208
12.7.3 PERVASIVE PLAYERS 208
12.7.4 PARTICIPANTS 208
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 209
12.7.5.1 Region footprint 210
12.7.5.2 Material footprint 211
12.7.5.3 Process technology footprint 212
12.7.5.4 Design/Process footprint 213
12.7.5.5 Application footprint 214
12.7.5.6 End user footprint 215
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 216
12.8.1 PROGRESSIVE COMPANIES 216
12.8.2 RESPONSIVE COMPANIES 216
12.8.3 DYNAMIC COMPANIES 216
12.8.4 STARTING BLOCKS 216
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 218
12.8.5.1 Detailed list of key startups/SMEs 218
12.8.5.2 Competitive benchmarking of key startups/SMEs 219
12.9 COMPETITIVE SCENARIO 220
12.9.1 PRODUCT LAUNCHES 220
12.9.2 DEALS 221
12.9.3 EXPANSIONS 222
12.9.4 OTHER DEVELOPMENTS 223
13 COMPANY PROFILES – MEDICAL FILTRATION EQUIPMENT PROVIDERS 224
13.1 KEY PLAYERS 224
13.1.1 MERCK KGAA 224
13.1.1.1 Business overview 224
13.1.1.2 Products/Solutions/Services offered 225
13.1.1.3 Recent developments 228
13.1.1.3.1 Expansions 228
13.1.1.4 MnM view 229
13.1.1.4.1 Right to win 229
13.1.1.4.2 Strategic choices 229
13.1.1.4.3 Weaknesses and competitive threats 230
13.1.2 3M (SOLVENTUM) 231
13.1.2.1 Business overview 231
13.1.2.2 Products/Solutions/Services offered 232
13.1.2.3 Recent developments 234
13.1.2.3.1 Other developments 234
13.1.2.4 MnM view 235
13.1.2.4.1 Right to win 235
13.1.2.4.2 Strategic choices 235
13.1.2.4.3 Weaknesses and competitive threats 235
13.1.3 DANAHER 236
13.1.3.1 Business overview 236
13.1.3.2 Products/Solutions/Services offered 237
13.1.3.3 Recent developments 240
13.1.3.3.1 Deals 240
13.1.3.3.2 Other developments 241
13.1.3.4 MnM view 241
13.1.3.4.1 Right to win 241
13.1.3.4.2 Strategic choices 241
13.1.3.4.3 Weaknesses and competitive threats 242
13.1.4 SARTORIUS AG 243
13.1.4.1 Business overview 243
13.1.4.2 Products/Solutions/Services offered 244
13.1.4.3 Recent developments 247
13.1.4.3.1 Product launches 247
13.1.4.4 MnM view 247
13.1.4.4.1 Right to win 247
13.1.4.4.2 Strategic choices 247
13.1.4.4.3 Weaknesses and competitive threats 247
13.1.5 ASAHI KASEI CORPORATION 248
13.1.5.1 Business overview 248
13.1.5.2 Products/Solutions/Services offered 249
13.1.5.3 MnM view 250
13.1.5.3.1 Right to win 250
13.1.5.3.2 Strategic choices 250
13.1.5.3.3 Weaknesses and competitive threats 250
13.1.6 BAXTER 251
13.1.6.1 Business overview 251
13.1.6.2 Products/Solutions/Services offered 252
13.1.6.3 Recent developments 254
13.1.6.3.1 Deals 254
13.1.6.4 MnM view 255
13.1.6.4.1 Right to win 255
13.1.6.4.2 Strategic choices 255
13.1.6.4.3 Weaknesses and competitive threats 255
13.1.7 THERMO FISHER SCIENTIFIC INC. 256
13.1.7.1 Business overview 256
13.1.7.2 Products/Solutions/Services offered 257
13.1.7.3 MnM view 260
 
13.1.8 VEOLIA 261
13.1.8.1 Business overview 261
13.1.8.2 Products/Solutions/Services offered 262
13.1.8.3 Recent developments 266
13.1.8.3.1 Product launches 266
13.1.8.4 MnM view 267
13.1.8.4.1 Right to win 267
13.1.8.4.2 Strategic choices 267
13.1.8.4.3 Weaknesses and competitive threats 267
13.1.9 DONALDSON COMPANY, INC. 268
13.1.9.1 Business overview 268
13.1.9.2 Products/Solutions/Services offered 269
13.1.9.3 Recent developments 270
13.1.9.3.1 Expansions 270
13.1.9.4 MnM view 270
13.1.10 PARKER HANNIFIN CORP 271
13.1.10.1 Business overview 271
13.1.10.2 Products/Solutions/Services offered 272
13.1.10.3 MnM view 273
13.1.11 ENTEGRIS 274
13.1.11.1 Business overview 274
13.1.11.2 Products/Solutions/Services offered 275
13.1.11.3 MnM view 275
13.1.12 MANN+HUMMEL 276
13.1.12.1 Business overview 276
13.1.12.2 Products/Solutions/Services offered 277
13.1.12.3 MnM view 278
13.2 OTHER PLAYERS 279
13.2.1 CORNING INCORPORATED 279
13.2.2 CRITICAL PROCESS FILTRATION, INC. 280
13.2.3 COBETTER 281
13.2.4 GRAVER TECHNOLOGIES 282
13.2.5 ERTELALSOP 284
13.2.6 KASAG SWISS AG 285
13.2.7 FILTROX AG 286
13.2.8 MEMBRANE SOLUTIONS 287
13.2.9 COLE-PARMER INSTRUMENT COMPANY, LLC 288
13.2.10 MEISSNER FILTRATION PRODUCTS, INC. 289
13.2.11 MEDICAL FILTRATION SOLUTIONS LTD. 290
13.2.12 SEFAR AG 291
13.2.13 WALKER FILTRATION 292
13.2.14 SAINT-GOBAIN 293
14 COMPANY PROFILES - AUTOMATED ENDOSCOPE REPROCESSOR PROVIDERS 294
14.1 KEY PLAYERS 294
14.1.1 STERIS 294
14.1.1.1 Business overview 294
14.1.1.2 Products/Solutions/Services offered 295
14.1.1.3 Recent developments 297
14.1.1.3.1 Deals 297
14.1.1.4 MnM view 297
14.1.1.4.1 Right to win 297
14.1.1.4.2 Strategic choices 298
14.1.1.4.3 Weaknesses and competitive threats 298
14.1.2 FORTIVE 299
14.1.2.1 Business overview 299
14.1.2.2 Products/Solutions/Services offered 300
14.1.2.3 Recent developments 301
14.1.2.3.1 Deals 301
14.1.2.4 MnM view 301
14.1.2.4.1 Right to win 301
14.1.2.4.2 Strategic choices 302
14.1.2.4.3 Weaknesses and competitive threats 302
14.1.3 OLYMPUS CORPORATION 303
14.1.3.1 Business overview 303
14.1.3.2 Products/Solutions/Services offered 304
14.1.3.3 Recent developments 305
14.1.3.3.1 Product launches 305
14.1.3.4 MnM view 305
14.1.3.4.1 Right to win 305
14.1.3.4.2 Strategic choices 305
14.1.3.4.3 Weaknesses and competitive threats 305
14.1.4 ECOLAB 306
14.1.4.1 Business overview 306
14.1.4.2 Products/Solutions/Services offered 307
14.1.4.3 Recent developments 308
14.1.4.3.1 Product launches 308
14.1.4.4 MnM view 308
14.1.4.4.1 Right to win 308
14.1.4.4.2 Strategic choices 308
14.1.4.4.3 Weaknesses and competitive threats 309
 
14.1.5 GETINGE 310
14.1.5.1 Business overview 310
14.1.5.2 Products/Solutions/Services offered 311
14.1.5.3 Recent developments 312
14.1.5.3.1 Expansions 312
14.1.5.4 MnM view 312
14.1.5.4.1 Right to win 312
14.1.5.4.2 Strategic choices 312
14.1.5.4.3 Weaknesses and competitive threats 313
14.1.6 STEELCOBELIMED (METALL ZUG GROUP) 314
14.1.6.1 Business overview 314
14.1.6.2 Products/Solutions/Services offered 315
14.1.6.3 Recent developments 316
14.1.6.3.1 Deals 316
14.1.6.4 MnM view 316
14.1.7 ENDO-TECHNIK W. GRIESAT (CREO) 317
14.1.7.1 Business overview 317
14.1.7.2 Products/Solutions/Services offered 317
14.1.7.3 MnM view 318
14.1.8 WASSENBURG MEDICAL B.V. (HOYA CORPORATION) 319
14.1.8.1 Business overview 319
14.1.8.2 Products/Solutions/Services offered 319
14.1.8.3 Recent developments 320
14.1.8.3.1 Deals 320
15 COMPANY PROFILES – DIALYSIS EQUIPMENT PROVIDERS 321
15.1 KEY PLAYERS 321
15.1.1 FRESENIUS MEDICAL CARE AG 321
15.1.1.1 Business overview 321
15.1.1.2 Products/Solutions/Services offered 322
15.1.1.3 Recent developments 323
15.1.1.3.1 Product launches 323
15.1.1.3.2 Deals 324
15.1.1.4 MnM view 324
15.1.1.4.1 Right to win 324
15.1.1.4.2 Strategic choices 325
15.1.1.4.3 Weaknesses and competitive threats 325
15.1.2 BAXTER 326
15.1.2.1 Business overview 326
15.1.2.2 Products/Solutions/Services offered 327
15.1.2.3 Recent developments 328
15.1.2.3.1 Deals 328
15.1.2.4 MnM view 329
15.1.2.4.1 Right to win 329
15.1.2.4.2 Strategic choices 329
15.1.2.4.3 Weaknesses and competitive threats 329
15.1.3 DAVITA INC. 330
15.1.3.1 Business overview 330
15.1.3.2 Products/Solutions/Services offered 331
15.1.3.3 Recent developments 331
15.1.3.3.1 Deals 331
15.1.3.3.2 Expansions 332
15.1.3.4 MnM view 332
15.1.3.4.1 Right to win 332
15.1.3.4.2 Strategic choices 332
15.1.3.4.3 Weaknesses and competitive threats 332
15.1.4 NIKKISO CO., LTD. 333
15.1.4.1 Business overview 333
15.1.4.2 Products/Solutions/Services offered 334
15.1.4.3 Recent developments 335
15.1.4.3.1 Deals 335
15.1.4.4 MnM view 336
15.1.4.4.1 Right to win 336
15.1.4.4.2 Strategic choices 336
15.1.4.4.3 Weaknesses and competitive threats 336
15.1.5 B. BRAUN SE 337
15.1.5.1 Business overview 337
15.1.5.2 Products/Solutions/Services offered 338
15.1.5.3 Recent developments 339
15.1.5.3.1 Product launches 339
15.1.5.3.2 Expansions 339
15.1.5.4 MnM view 340
15.1.5.4.1 Right to win 340
15.1.5.4.2 Strategic choices 340
15.1.5.4.3 Weaknesses and competitive threats 340
15.1.6 NIPRO 341
15.1.6.1 Business overview 341
15.1.6.2 Products/Solutions/Services offered 342
15.1.6.3 Recent developments 343
15.1.6.3.1 Product launches 343
15.1.7 TORAY MEDICAL CO., LTD. 344
15.1.7.1 Business overview 344
15.1.7.2 Products/Solutions/Services offered 345
 
15.1.8 MEDIONICS 346
15.1.8.1 Business overview 346
15.1.8.2 Products/Solutions/Services offered 346
16 APPENDIX 347
16.1 DISCUSSION GUIDE 347
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 350
16.3 CUSTOMIZATION OPTIONS 352
16.4 RELATED REPORTS 352
16.5 AUTHOR DETAILS 353